SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (881)8/21/1998 2:49:00 PM
From: Colby  Read Replies (1) of 1016
 
Brad,
l certainly can't argue your predictions thus far, but I'm thinking 0 is a little far fetched. Even if VVUS were stop competing in the US market altogether, they would probably still be able to be profitable, especially with somebody else doing there marketing. All of VVUS's blunders have been because of their US operations. Internationally, all they have to do is produce, which, thus far, I think they have done well. I am not saying I want this scenario, but my point is even without the US they still have something.

Just some food for thought,
Colby
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News